Immune function testing of human pharmaceuticals: Regulatory overshoot?

Expert Opinion on Drug Safety

Volumn 4, Issue 1, 2005, Pages 1-5

  van der Laan, Jan Willem ^a   van Loveren, Henk ^a  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

Developmental immunotoxicity; Human pharmaceuticals; Immune function testing; Immunotoxicity; Routine screening

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; ANTIINFLAMMATORY AGENT; AZATHIOPRINE; CYCLOSPORIN A; CYTOKINE; DIOXIN; IMMUNOSUPPRESSIVE AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OXIDIZING AGENT; POLYCHLORINATED BIPHENYL; SEROTONIN UPTAKE INHIBITOR; T LYMPHOCYTE ANTIGEN;

ADVISORY COMMITTEE; ANTIBODY RESPONSE; CANCER RISK; CONSENSUS DEVELOPMENT; DOSE RESPONSE; DRUG INDUCED DISEASE; DRUG RECEPTOR BINDING; DRUG SCREENING; DRUG SENSITIVITY; EDITORIAL; ENVIRONMENTAL FACTOR; EUROPEAN UNION; FLUORESCENCE ACTIVATED CELL SORTER; FOOD AND DRUG ADMINISTRATION; HEMATOLOGICAL PARAMETERS; HISTOPATHOLOGY; HUMAN; IMMUNE DEFICIENCY; IMMUNE FUNCTION TEST; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOPATHOLOGY; IMMUNOSUPPRESSIVE TREATMENT; IMMUNOTOXICITY; KAPOSI SARCOMA; LEUKOCYTE DIFFERENTIAL COUNT; LYMPHOID ORGAN; LYMPHOMA; LYMPHOPROLIFERATIVE DISEASE; NATURAL KILLER CELL; NONHUMAN; POSTNATAL DEVELOPMENT; SKIN CANCER; SYSTEMATIC REVIEW; ULTRAVIOLET RADIATION;

BIOLOGICAL ASSAY; DRUG EVALUATION, PRECLINICAL; EUROPE; HEALTH POLICY; HUMANS; IMMUNE SYSTEM; IMMUNOSUPPRESSION; INTERNATIONAL COOPERATION; PHARMACEUTICAL PREPARATIONS; TOXICITY TESTS;

EID: 12544252102     PISSN: 14740338     EISSN: None     Source Type: Journal    
DOI: 10.1517/14740338.4.1.1     Document Type: Editorial

References (17)

1. VOS J, VAN LOVEREN H: Experimental studies on immunosuppression: how do they predict for man? Toxicology (1998) 129:13-26.
2. DE HEER C, SCHUURMAN HJ, HOUBEN GF, PIETERS RH, PENNINKS AH, VAN LOVEREN H: The SCID-hu mouse as a tool in immunotoxicological risk assessment: effets of 2-acetyl-4(5)-tetrahydroxybutyl-imidazole (THI) and di-n-butyltin dichloride (DBTC) on the human thymus in SCID-hu mice. Toxicology (1995) 100(1-3):203-211.
3. HOLLADAY SD, LINDSTROM P, BLAYLOCK BL et al.: Perinatal thymocyte antigen expression and postnatal immune development altered by gestational exposure to tetrachlorodibenzo-p-dioxin (TCDD). Teratology (1991) 44(4):385-393.
4. WEISGLAS-KUPERUS N, PATANDIN S, BERBERS GA et al.: Immunologic effects of background exposure to polychlorinated biphenyls and dioxins in Dutch preschool children. Environ. Health Perspect. (2000) 108(12):1203-1207.
5. DALLAIRE F, DEWAILLY E, MUCKLE G, VEZINA C, JACOBSON SW, AYOTTE P: Acute infections and environmental exposure to organochlorines in Inuit infants from Nunavik. Env. Health. Persp. (2004) 112 1359-1365.
6. TERMORSHUIZEN F, FELTKAMP MC, STRUIJK L, DE GRUIJL FR, BOUWES-BAVINCK JN, VAN LOVEREN H: Sunlight exposure and (sero)prevalence of epidermodysplasia verriciformis-associated human papillomavirus. J. Invest. Dermatol. (2004) 122:1456-1462.
7. TERMORSHUIZEN F, WIJGA A. GERRITSEN J, NIJENS HJ, VAN LOVEREN H: Exposure to ultraviolet radiation and upper respiratory tract symptoms in 1-year old children. Photodermatol. Photoimmunol. Photomed. (2004) 20:270-271.
8. DE WAAL EJ, DE JONG WH, VAN DER VLIET H, VERLAAN B, VAN LOVEREN H: An immunotoxicity screening study on salmeterol in rats. Int. J. Immunopharmacol. (1996) 18(8-9):523-528.
9. DE WAAL EJ, VAN DER LAAN JW, VAN LOVEREN H: Effects of prolonged exposure to morphine and methadone on in vivo parameters of immune function in rats. Toxicology (1998) 129 2-3):201-210.
10. DE WAAL EJ, DE JONG WH, VAN DER STAPPEN AJ, VERLAAN B, VAN LOVEREN H: Effects of salmeterol on host resistance to Trichinella spiralis in rats. Int. J. Immunopharmacol. (1999) 21 8):523-529.
11. VAN DER LAAN JW, KRAJNC EI, KRAJNC-FRANKEN MA, VAN LOVEREN H: Immunotoxicological screening of morphine and methadone in an extended 28 day study in rats. Int. J. Immunopharmacol. (1995) 17 6):535-543.
12. LUSTER MI, PORTIER C, PAIT DG et al.: Risk assessment in immunotoxicology. I. Sensitivity and predictability of immune tests. Fundam. Appl. Toxicol. (1992) 18(2):200-210.
13. LUSTER MI, PORTIER C, PAIT DG et al.: Risk assessment in immunotoxicology. II. Relationships between immune and host resistance tests Fundam. Appl. Toxicol. (1993) 21(1):71-82.
14. KUPER CF, HARLEMAN JH, RICHTER-REICHHELM HB, VOS JG: Histopathologic approaches to detect changes indicative of immunotoxicity. Toxicol. Pathol. (2000) 28:454-466.
15. GERMOLEC DR, NYSKA A, KASHON M et al.: Extended histopathology in immunotoxicity testing: interlaboratory validation studies. Toxicol. Sci. (2004) 78:107-115
16. HOLSAPPLE MP, WEST, LJ, LANDRETH KS: Species comparison of anatomical and functional Immune system development. Birth Defects Res. Part B (2003) 68:321-334.
17. HOLSAPPLE MP, LAVIN AL, BURNS-NAAS LA et al.: A proposed testing framework for developmental immunotoxicology. Toxicol. Sci. (2004) In press.